Suppr超能文献

经直肠和经会阴前列腺活检术加用或不加用抗生素预防的疗效和并发症比较。

Comparisons of efficacy and complications between transrectal and transperineal prostate biopsy with or without antibiotic prophylaxis.

机构信息

Department of Urology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.

Department of Organ Transplant, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

出版信息

Urol Oncol. 2022 May;40(5):191.e9-191.e14. doi: 10.1016/j.urolonc.2022.01.004. Epub 2022 Feb 12.

Abstract

BACKGROUND AND PURPOSE

We aimed to determine the cancer detection rate and complications of transrectal prostate biopsy (TRBx) and transperineal prostate biopsy (TPBx) in the hospital. However, given the use of antibiotic prophylaxis in TPBx remains controversial according to the current guidelines, we also investigated the safety and side effects of TPBx with and without antibiotic prophylaxis.

MATERIALS AND METHODS

A total of 777 patients who underwent prostate biopsy were enrolled in this study in accordance with the criteria. The primary outcome was pooled infectious complications (sepsis, fever, symptomatic urinary tract infection and urinary retention), and the secondary outcome was prostate cancer detection rate.

RESULTS

Findings showed that TPBx and TRBx were equivalent in terms of prostate cancer detection rate (TPBx: 50.4% vs. TRBx: 47.3%; P = 0.424) and urinary retention (TPBx: 5% vs. TRBx: 6.3%; P = 0.451). However, TRBx had significantly higher incidences of sepsis (risk ratios, RR: 3.65, 95% confidence interval [CI]: 1.21-11.03; P = 0.014) and symptomatic urinary tract infection (RR: 3.04, 95% CI: 1.07-8.66; P = 0.029) than TPBx. Notably, for TPBx, patients who received a single dose of cephazolin prophylaxis were not associated with the risk of sepsis (RR: 0.78, 95% CI: 0.13-4.63; P = 0.783) and symptomatic urinary tract infection (RR: 1.17, 95% CI: 0.24-5.74; P = 0.848) in contrast to patients who did not receive any antibiotic prophylaxis. Meanwhile, no effects on prostate cancer detection rate and urinary retention were observed in the TPBx group.

CONCLUSIONS

Our findings indicated that TPBx significantly reduced infectious complications compared with TRBx and should therefore be preferred. Importantly, we need to re-examine whether the antibiotic prophylaxis should be routinely applied before TPBx in consideration of increasing antibiotic resistance. This result complements the current national guidelines. Nevertheless, future studies on this topic with improved quality and increased sample size are still needed to minimise bacterial resistance.

摘要

背景与目的

我们旨在确定医院中经直肠前列腺活检(TRBx)和经会阴前列腺活检(TPBx)的癌症检出率和并发症。然而,根据目前的指南,TPBx 中使用抗生素预防仍存在争议,因此我们还研究了有和没有抗生素预防的 TPBx 的安全性和副作用。

材料与方法

根据标准,共有 777 名接受前列腺活检的患者纳入本研究。主要结局为感染性并发症(败血症、发热、有症状的尿路感染和尿潴留)的汇总,次要结局为前列腺癌检出率。

结果

研究结果表明,TPBx 和 TRBx 在前列腺癌检出率(TPBx:50.4% vs. TRBx:47.3%;P=0.424)和尿潴留(TPBx:5% vs. TRBx:6.3%;P=0.451)方面相当。然而,TRBx 的败血症(风险比,RR:3.65,95%置信区间[CI]:1.21-11.03;P=0.014)和有症状的尿路感染(RR:3.04,95%CI:1.07-8.66;P=0.029)的发生率明显高于 TPBx。值得注意的是,对于 TPBx,接受单次头孢唑林预防的患者与败血症(RR:0.78,95%CI:0.13-4.63;P=0.783)和有症状的尿路感染(RR:1.17,95%CI:0.24-5.74;P=0.848)的风险无关,而未接受任何抗生素预防的患者则有相关风险。同时,在 TPBx 组中未观察到对前列腺癌检出率和尿潴留的影响。

结论

我们的研究结果表明,与 TRBx 相比,TPBx 显著降低了感染性并发症,因此应优先选择 TPBx。重要的是,由于考虑到抗生素耐药性的增加,我们需要重新审视在 TPBx 之前是否应常规应用抗生素预防。这一结果补充了当前的国家指南。然而,仍需要进行更多高质量和更大样本量的关于该主题的研究,以最大限度地减少细菌耐药性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验